Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Genome Biology
|
May 10, 2021
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
Eros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, et al.
Frontiers in Physiology
|
May 24, 2019
Mitochondrial Adaptations in Elderly and Young Men Skeletal Muscle Following 2 Weeks of Bed Rest and Rehabilitation
Alessia Buso, Marina Comelli, Raffaella Picco, et al.
ACS Omega
|
December 20, 2021
hnRNPA1/UP1 Unfolds <i>KRAS</i> G-Quadruplexes and Feeds a Regulatory Axis Controlling Gene Expression
Annalisa Ferino, Julien Marquevielle, Himanshi Choudhary, et al.
Journal of Medicinal Chemistry
|
February 3, 2015
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent
Ulma Cersosimo, Andrea Sgorbissa, Carmen Foti, et al.
Plos Genetics
|
April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness
Eros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Oncotarget
|
June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells
Andrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 30, 2024
The central role of creatine and polyamines in fetal growth restriction
Eros Di Giorgio, Serena Xodo, Maria Orsaria, et al.
Cell Death Discovery
|
November 10, 2025
Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cells
Eleonora Malavasi, Raffaella Picco, Showmeya Mallavarapu, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>
Luca Iuliano, Sara Drioli, Ymera Pignochino, et al.
Molecular Oncology
|
November 1, 2025
Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Genome Biology
|
May 10, 2021
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
Eros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, et al.
Frontiers in Physiology
|
May 24, 2019
Mitochondrial Adaptations in Elderly and Young Men Skeletal Muscle Following 2 Weeks of Bed Rest and Rehabilitation
Alessia Buso, Marina Comelli, Raffaella Picco, et al.
ACS Omega
|
December 20, 2021
hnRNPA1/UP1 Unfolds <i>KRAS</i> G-Quadruplexes and Feeds a Regulatory Axis Controlling Gene Expression
Annalisa Ferino, Julien Marquevielle, Himanshi Choudhary, et al.
Journal of Medicinal Chemistry
|
February 3, 2015
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent
Ulma Cersosimo, Andrea Sgorbissa, Carmen Foti, et al.
Plos Genetics
|
April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness
Eros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Oncotarget
|
June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells
Andrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 30, 2024
The central role of creatine and polyamines in fetal growth restriction
Eros Di Giorgio, Serena Xodo, Maria Orsaria, et al.
Cell Death Discovery
|
November 10, 2025
Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cells
Eleonora Malavasi, Raffaella Picco, Showmeya Mallavarapu, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>
Luca Iuliano, Sara Drioli, Ymera Pignochino, et al.
Molecular Oncology
|
November 1, 2025
Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, et al.
Page
of 3